SG Americas Securities’s Clover Health Investments CLOV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
Sell
-130,000
Closed -$1.01M 3833
2021
Q2
$1.01M Buy
130,000
+10,000
+8% +$98.2K ﹤0.01% 1546
2021
Q1
$900K Buy
+120,000
New +$1.35M ﹤0.01% 1624

Other funds holding CLOV

SG Americas Securities's CLOV Position: Q2 2026 in Review

SG Americas Securities increased its Clover Health Investments (CLOV) stake by 71% in Q2 2026, buying an estimated $347K and bringing the position to 245,875 shares worth $1.29M. The position accounts for ﹤0.01% of the portfolio, ranked #1728.

SG Americas Securities first reported a position in CLOV in Q1 2021 and has held it in 13 quarters since. The position peaked at $2.75M in Q2 2021. 227 funds tracked by Wall St. Rank hold CLOV as of Q2 2026.

  • SG Americas Securities held 245,875 shares of Clover Health Investments worth $1.29M as of Q2 2026.
  • SG Americas Securities bought 102,116 Clover Health Investments shares in Q2 2026, an estimated $347K.
  • Clover Health Investments made up ﹤0.01% of SG Americas Securities's portfolio in Q2 2026, its #1728 holding.
  • SG Americas Securities first reported a position in Clover Health Investments in Q1 2021 and has held it in 13 quarters since.
  • SG Americas Securities's Clover Health Investments position peaked at $2.75M in Q2 2021.
  • 227 funds tracked by Wall St. Rank held Clover Health Investments as of Q2 2026.

Based on SG Americas Securities's 13F filing for Q2 2026, filed 7 Aug 2026.